Intermolecular Company Profile (NASDAQ:IMI)

About Intermolecular (NASDAQ:IMI)

Intermolecular logoIntermolecular, Inc. provides thin film solutions. The Company's high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems. It develops technology and Internet protocol (IP) rights focused on materials, processes, integration and device architectures in collaboration with its customers. Its HPC platform consists of tempus HPC processing, automated characterization and informatics and analysis software. The Company offers a series of wet processing tools and dry processing tools. Its informatics software includes workflow management software, analysis and reporting software, security and collaboration management software, and integration services. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Semiconductors
  • Sub-Industry: Semiconductors
  • Symbol: NASDAQ:IMI
  • CUSIP: 45882D10
  • Web:
  • Market Cap: $50.05 million
  • Outstanding Shares: 49,560,000
Average Prices:
  • 50 Day Moving Avg: $0.91
  • 200 Day Moving Avg: $0.91
  • 52 Week Range: $0.78 - $1.20
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.10
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $39.08 million
  • Price / Sales: 1.28
  • Book Value: $0.75 per share
  • Price / Book: 1.35
  • EBIDTA: ($5,320,000.00)
  • Net Margins: -47.22%
  • Return on Equity: -43.57%
  • Return on Assets: -35.71%
  • Current Ratio: 4.20%
  • Quick Ratio: 4.20%
  • Average Volume: 23,927 shs.
  • Beta: 0.94
  • Short Ratio: 1.36

Frequently Asked Questions for Intermolecular (NASDAQ:IMI)

What is Intermolecular's stock symbol?

Intermolecular trades on the NASDAQ under the ticker symbol "IMI."

How were Intermolecular's earnings last quarter?

Intermolecular, Inc. (NASDAQ:IMI) released its quarterly earnings results on Thursday, February, 12th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of ($0.10). The company had revenue of $11 million for the quarter, compared to the consensus estimate of $10.40 million. Intermolecular had a negative net margin of 47.22% and a negative return on equity of 43.57%. View Intermolecular's Earnings History.

Who are some of Intermolecular's key competitors?

Who are Intermolecular's key executives?

Intermolecular's management team includes the folowing people:

  • Bill Roeschlein, Chief Financial Officer, Principal Financial & Principal Accounting Officer
  • Bruce M. McWilliams Ph.D., Non-Executive Chairman of the Board
  • Matthew Furnas, Director
  • Christian F. Kramer, Director
  • Marvin D. Burkett, Independent Director
  • Irwin B. Federman, Independent Director

Who owns Intermolecular stock?

Intermolecular's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Symmetry Peak Management LLC (2.06%), Vanguard Group Inc. (1.03%) and Royce & Associates LP (0.56%). Company insiders that own Intermolecular stock include Irwin Federman, Lloyd I Miller III, Rick Neely and William C Martin. View Institutional Ownership Trends for Intermolecular.

Who sold Intermolecular stock? Who is selling Intermolecular stock?

Intermolecular's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. View Insider Buying and Selling for Intermolecular.

How do I buy Intermolecular stock?

Shares of Intermolecular can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intermolecular's stock price today?

One share of Intermolecular stock can currently be purchased for approximately $1.01.

MarketBeat Community Rating for Intermolecular (NASDAQ IMI)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  77 (Vote Underperform)
Total Votes:  134
MarketBeat's community ratings are surveys of what our community members think about Intermolecular and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Intermolecular (NASDAQ:IMI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Intermolecular (NASDAQ:IMI)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/16/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
9/29/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$2.22 -> $3.00N/AView Rating Details
(Data available from 9/20/2015 forward)


Earnings History for Intermolecular (NASDAQ:IMI)
Earnings by Quarter for Intermolecular (NASDAQ:IMI)
Earnings History by Quarter for Intermolecular (NASDAQ IMI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/9/2017Q416($0.08)($0.05)$10.20 million$10.50 millionViewListenView Earnings Details
2/12/2015Q414($0.10)($0.10)$10.40 million$11.00 millionViewN/AView Earnings Details
10/31/2014Q314($0.09)($0.07)$10.60 million$10.90 millionViewN/AView Earnings Details
8/1/2014Q2 2014($0.19)($0.14)$9.00 million$9.93 millionViewN/AView Earnings Details
5/6/2014Q1($0.05)($0.06)$15.51 million$15.91 millionViewN/AView Earnings Details
2/6/2014($0.07)($0.07)$15.57 million$15.60 millionViewN/AView Earnings Details
2/6/2014($0.07)($0.07)$15.57 million$15.60 millionViewN/AView Earnings Details
2/6/2014Q413($0.07)($0.07)$15.57 million$15.60 millionViewN/AView Earnings Details
10/24/2013Q313($0.03)($0.05)$15.50 million$17.70 millionViewN/AView Earnings Details
7/25/2013Q213($0.01)$0.01$16.54 million$16.60 millionViewN/AView Earnings Details
4/25/2013Q1 2013$0.03$16.97 million$17.43 millionViewN/AView Earnings Details
2/7/2013Q4 2013$0.01$0.03$16.68 million$17.40 millionViewN/AView Earnings Details
10/25/2012($0.03)$0.02ViewN/AView Earnings Details
7/26/2012($0.03)($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Intermolecular (NASDAQ:IMI)
Current Year EPS Consensus Estimate: $-0.20 EPS
Next Year EPS Consensus Estimate: $-0.10 EPS


Dividend History for Intermolecular (NASDAQ:IMI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Intermolecular (NASDAQ:IMI)
Insider Ownership Percentage: 45.40%
Institutional Ownership Percentage: 37.96%
Insider Trades by Quarter for Intermolecular (NASDAQ:IMI)
Institutional Ownership by Quarter for Intermolecular (NASDAQ:IMI)
Insider Trades by Quarter for Intermolecular (NASDAQ:IMI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2017Lloyd I Miller IIIMajor ShareholderBuy600$0.86$516.00View SEC Filing  
9/5/2017Lloyd I Miller IIIMajor ShareholderBuy1,909$0.86$1,641.74View SEC Filing  
9/1/2017Lloyd I Miller IIIMajor ShareholderBuy34,109$0.86$29,333.74View SEC Filing  
8/31/2017Lloyd I Miller IIIMajor ShareholderBuy1,612$0.86$1,386.32View SEC Filing  
8/28/2017Lloyd I Miller IIIMajor ShareholderBuy400$0.86$344.00View SEC Filing  
8/21/2017Lloyd I Miller IIIMajor ShareholderBuy300$0.86$258.00View SEC Filing  
6/22/2017Lloyd I Miller IIIMajor ShareholderBuy80,000$0.88$70,400.00View SEC Filing  
6/20/2017Lloyd I Miller IIIMajor ShareholderBuy6,659$0.86$5,726.74View SEC Filing  
5/24/2017Lloyd I Miller IIIMajor ShareholderBuy107$0.85$90.95View SEC Filing  
5/23/2017Lloyd I Miller IIIMajor ShareholderBuy29,020$0.85$24,667.00View SEC Filing  
5/22/2017Lloyd I Miller IIIMajor ShareholderBuy5,590$0.85$4,751.50View SEC Filing  
5/19/2017Lloyd I Miller IIIMajor ShareholderBuy6,564$0.85$5,579.40View SEC Filing  
5/18/2017Lloyd I Miller IIIMajor ShareholderBuy2,132$0.85$1,812.20View SEC Filing  
5/17/2017Lloyd I Miller IIIMajor ShareholderBuy12,743$0.85$10,831.55View SEC Filing  
5/16/2017Lloyd I Miller IIIMajor ShareholderBuy9,325$0.85$7,926.25View SEC Filing  
5/15/2017Lloyd I Miller IIIMajor ShareholderBuy8,817$0.85$7,494.45View SEC Filing  
5/12/2017Lloyd I Miller IIIMajor ShareholderBuy4,642$0.85$3,945.70View SEC Filing  
2/28/2017Rick NeelyCFOSell1,145$1.02$1,167.90View SEC Filing  
12/16/2016William C MartinMajor ShareholderBuy214,294$1.02$218,579.88View SEC Filing  
11/18/2016William C MartinMajor ShareholderBuy400$1.00$400.00View SEC Filing  
11/17/2016William C MartinMajor ShareholderBuy990,452$0.85$841,884.20View SEC Filing  
10/14/2016Rick NeelyCFOSell4,586$0.95$4,356.70View SEC Filing  
8/15/2016Irwin FedermanDirectorBuy100,000$1.25$125,000.00View SEC Filing  
8/12/2016William C MartinMajor ShareholderBuy10,944$1.25$13,680.00View SEC Filing  
8/11/2016William C MartinMajor ShareholderBuy2,165,634$1.02$2,208,946.68View SEC Filing  
5/17/2016Irwin FedermanDirectorBuy100,000$1.90$190,000.00View SEC Filing  
3/1/2016Rick NeelyCFOSell940$2.18$2,049.20View SEC Filing  
2/24/2016Irwin FedermanDirectorBuy5,900$2.12$12,508.00View SEC Filing  
2/16/2016Irwin FedermanDirectorBuy4,716$2.12$9,997.92View SEC Filing  
2/11/2016Irwin FedermanDirectorBuy17,878$2.10$37,543.80View SEC Filing  
12/9/2015Irwin FedermanDirectorBuy5,603$2.05$11,486.15View SEC Filing  
12/8/2015Irwin FedermanDirectorBuy1,600$2.04$3,264.00View SEC Filing  
12/7/2015Irwin FedermanDirectorBuy200$2.05$410.00View SEC Filing  
11/17/2015Irwin FedermanDirectorBuy4,600$2.03$9,338.00View SEC Filing  
11/16/2015Irwin FedermanDirectorBuy64,300$2.00$128,600.00View SEC Filing  
10/5/2015Rick NeelyCFOSell3,807$1.86$7,081.02View SEC Filing  
9/23/2015William C MartinMajor ShareholderBuy283,913$1.75$496,847.75View SEC Filing  
6/25/2015Rick NeelyCFOSell33,407$1.95$65,143.65View SEC Filing  
11/13/2014Irwin FedermanDirectorBuy50,000$2.14$107,000.00View SEC Filing  
11/4/2014Irwin FedermanDirectorBuy100,000$2.25$225,000.00View SEC Filing  
10/3/2014Rick NeelyCFOSell3,884$2.31$8,972.04View SEC Filing  
7/29/2014Hector Thomas BlancoVPSell3,032$2.24$6,791.68View SEC Filing  
7/23/2014Hector Thomas BlancoVPSell1,968$2.20$4,329.60View SEC Filing  
5/1/2014Sandeep JaggiSVPSell5,569$2.70$15,036.30View SEC Filing  
3/31/2014Raj JammySVPSell5,356$2.76$14,782.56View SEC Filing  
3/3/2014Tony ChiangCTOSell1,476$2.64$3,896.64View SEC Filing  
2/6/2014David LazovskyCEOSell4,552$4.02$18,299.04View SEC Filing  
1/28/2014Sandeep JaggiSVPSell2,322$4.06$9,427.32View SEC Filing  
1/28/2014Sandeep NijhawanVPSell4,064$4.06$16,499.84View SEC Filing  
1/28/2014Tony ChiangCTOSell1,742$4.06$7,072.52View SEC Filing  
12/10/2013David LazovskyCEOSell38,500$5.33$205,205.00View SEC Filing  
12/4/2013Tony ChiangCTOSell30,000$5.52$165,600.00View SEC Filing  
11/8/2013David LazovskyCEOSell38,500$5.58$214,830.00View SEC Filing  
10/8/2013David LazovskyCEOSell38,500$5.80$223,300.00View SEC Filing  
9/9/2013David E LazovskyCEOSell38,500$5.89$226,765.00View SEC Filing  
9/5/2013Tony ChiangCTOSell39,003$5.97$232,847.91View SEC Filing  
8/7/2013David LazovskyCEOSell38,500$6.20$238,700.00View SEC Filing  
8/1/2013Tony P ChiangCTOSell48,000$6.31$302,880.00View SEC Filing  
7/16/2013Peter L EidelmanCFOSell21,753$6.96$151,400.88View SEC Filing  
7/8/2013David E LazovskyCEOSell38,500$7.34$282,590.00View SEC Filing  
7/3/2013Tony P ChiangCTOSell78,000$7.23$563,940.00View SEC Filing  
6/17/2013Peter L EidelmanCFOSell6,500$7.30$47,450.00View SEC Filing  
6/7/2013David E LazovskyCEOSell38,500$8.22$316,470.00View SEC Filing  
6/3/2013James Craig HunterSVPSell3,500$8.43$29,505.00View SEC Filing  
5/23/2013Tony P ChiangCTOSell52,926$8.40$444,578.40View SEC Filing  
5/16/2013Peter L EidelmanCFOSell6,500$8.68$56,420.00View SEC Filing  
3/25/2013Tony P ChiangCTOSell25,000$9.53$238,250.00View SEC Filing  
2/26/2013Tony P ChiangCTOSell72,612$9.55$693,444.60View SEC Filing  
2/21/2013Bruce M McwilliamsDirectorSell2,132$9.64$20,552.48View SEC Filing  
1/17/2013Bruce M McwilliamsDirectorSell21,200$9.27$196,524.00View SEC Filing  
12/3/2012John R BehnkeSVPSell2,500$6.99$17,475.00View SEC Filing  
10/8/2012David E LazovskyCEOSell26,810$7.23$193,836.30View SEC Filing  
9/5/2012James Craig HunterSVPSell3,500$7.20$25,200.00View SEC Filing  
8/23/2012Tony P ChiangCTOSell14,266$7.15$102,001.90View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Intermolecular (NASDAQ:IMI)
Latest Headlines for Intermolecular (NASDAQ:IMI)
DateHeadline logoWhat Does Intermolecular Inc’s (IMI) Share Price Indicate? - September 15 at 12:47 AM logoIntermolecular, Inc. (IMI) Major Shareholder Lloyd I. Miller III Buys 34,109 Shares - September 5 at 1:38 PM logoETFs with exposure to Intermolecular, Inc. : August 31, 2017 - August 31 at 7:49 PM logoIntermolecular, Inc. :IMI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 - August 26 at 6:13 AM logoIntermolecular to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017 - August 25 at 7:05 AM logoIntermolecular (IMI) versus Exar (EXAR) Head-To-Head Survey - August 18 at 12:22 AM logoEdited Transcript of IMI earnings conference call or presentation 8-Aug-17 9:00pm GMT - August 9 at 5:34 AM logoIntermolecular Announces Second Quarter 2017 Financial Results - August 8 at 7:30 PM logoIntermolecular Inc (IMI) Upgraded to Sell at ValuEngine - August 7 at 11:50 PM logoIntermolecular's High-Throughput Experimentation Platform Speeds Discovery of Next-Generation Non-Volatile Memories - August 1 at 3:25 PM logoIntermolecular To Report Second Quarter Fiscal 2017 Financial Results on August 8, 2017 - July 14 at 3:50 AM logoLloyd I. Miller III Acquires 80,000 Shares of Intermolecular, Inc. (IMI) Stock - June 23 at 5:08 PM logoETFs with exposure to Intermolecular, Inc. : May 25, 2017 - May 26 at 2:17 AM logoLloyd I. Miller III Buys 29,020 Shares of Intermolecular Inc (IMI) Stock - May 24 at 1:24 PM logoIntermolecular Inc (IMI) Major Shareholder Acquires $10,831.55 in Stock - May 18 at 4:54 PM logoETFs with exposure to Intermolecular, Inc. : May 11, 2017 - May 11 at 6:29 PM logoIntermolecular, Inc. :IMI-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 - May 10 at 1:20 PM logoEdited Transcript of IMI earnings conference call or presentation 4-May-17 9:00pm GMT - May 5 at 5:52 PM logoSomewhat Favorable News Coverage Very Likely to Impact Intermolecular (IMI) Stock Price - May 4 at 8:52 PM logoIntermolecular reports 1Q loss - May 4 at 7:57 PM logoInvestor Network: Intermolecular, Inc. to Host Earnings Call - May 4 at 6:04 PM logoIntermolecular Announces First Quarter 2017 Financial Results - May 4 at 6:04 PM logoIntermolecular (IMI) Getting Somewhat Positive News Coverage, Report Shows - May 1 at 7:32 PM logoSomewhat Favorable Media Coverage Extremely Likely to Affect Intermolecular (IMI) Share Price - April 27 at 3:36 PM logoIntermolecular (IMI) Earning Positive News Coverage, Analysis Shows - April 24 at 1:32 PM logoIntermolecular (IMI) Earning Favorable Media Coverage, Report Shows - April 20 at 11:09 AM logoIntermolecular (IMI) Given Daily Coverage Optimism Rating of 0.23 - April 17 at 11:51 PM logoIntermolecular (IMI) Earns Coverage Optimism Rating of 0.03 - April 14 at 6:52 PM logoIntermolecular To Report First Quarter Fiscal 2017 Financial Results on May 4, 2017 - April 13 at 5:38 PM logoETFs with exposure to Intermolecular, Inc. : April 7, 2017 - April 7 at 5:46 PM logoIntermolecular Announces Restructuring Initiative and Changes in its Leadership Team - March 29 at 6:25 PM logo4:18 pm Intermolecular appoints Bill Roeschlein, currently VP of Finance and Corporate Controller, as CFO; also announces restructuring initiative that will lower costs by approx. $4 mln in 2017 - March 29 at 6:25 PM logoINTERMOLECULAR INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or Prin - March 29 at 6:25 PM logoINTERMOLECULAR INC Files SEC form 10-K, Annual Report - March 3 at 5:53 PM logoQ4 2016 Intermolecular Inc Earnings Release - After Market Close - February 10 at 6:39 PM logoINTERMOLECULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi - February 10 at 6:39 PM logoEdited Transcript of IMI earnings conference call or presentation 9-Feb-17 10:00pm GMT - February 10 at 6:39 PM logoIntermolecular Announces Fourth Quarter 2016 and Full Year 2016 Financial Results - February 9 at 6:49 PM logoPOET Technologies Appoints David Lazovsky as Executive Chairman of Board - February 1 at 6:39 PM logoIntermolecular To Report Fourth Quarter and Fiscal Year 2016 Financial Results on February 9, 2017 - January 12 at 6:22 PM logoINTERMOLECULAR INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - November 16 at 5:52 PM logoEdited Transcript of IMI earnings conference call or presentation 2-Nov-16 9:00pm GMT - November 3 at 5:34 PM logoIntermolecular Announces Third Quarter 2016 Financial Results - November 2 at 5:50 PM logoQ3 2016 Intermolecular Inc Earnings Release - After Market Close - November 2 at 9:02 AM logoIntermolecular To Report Third Quarter Fiscal 2016 Financial Results on November 2, 2016 - October 13 at 5:38 PM logoINTERMOLECULAR INC Files SEC form 8-K, Change in Directors or Principal Officers - September 23 at 8:34 AM logoINTERMOLECULAR INC Financials - August 13 at 5:26 PM logoIntermolecular to Present at 2016 Flash Memory Summit on How High-Throughput Experimentation Can Identify … - August 10 at 5:54 PM logoIntermolecular, Inc. (IMI) - August 6 at 5:49 PM logoEdited Transcript of IMI earnings conference call or presentation 4-Aug-16 9:00pm GMT - August 6 at 5:49 PM



Intermolecular (IMI) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by Staff